Young laboratory woman with testtubes

Recent News

January 2018

Dr Fiona Dempsey (Director of Scientific Operations, aTen Therapeutics) joined Rose Maciewicz from AstraZeneca to address Glasgow University postdocs about industry careers.

November 2017

aTen Therapeutics’ Tina Flatau facilitates panel discussion on “Patient Centricity” at Pharma Integrates 2017 in London

aTen Therapeutics

An innovative biotechnology company.

We are developing novel therapeutic antibody approaches to target a fundamental control pathway associated with several major diseases. These novel approaches give aTen Therapeutics the potential to develop powerful new treatments to extend and improve lives.

Tensinomab product logo

Our novel antibody with huge therapeutic potential.

info@atentherapeutics.com

© aTen Therapeutics 2018. All rights reserved